Related Experiment Video

Updated: Jun 26, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Management of hyperlipidemia in older adults

Karen P Alexander1, Michael A Blazing, Robert S Rosenson

  • 1Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27715, USA. alexa019@mc.duke.edu

Journal of Cardiovascular Pharmacology and Therapeutics
|January 7, 2009
PubMed

Insights

Cardiovascular disease prevention is vital in older adults. Lowering low-density lipoprotein cholesterol with statins can reduce risk, but use and adherence remain suboptimal in this population.

Area of Science:

  • Gerontology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is a primary cause of mortality in individuals over 65.
  • Elevated low-density lipoprotein cholesterol (LDL-C) is a significant risk factor for CVD, even in older adults.
  • Lipid-lowering therapies, particularly statins, are crucial for reducing cardiovascular events.

Purpose of the Study:

  • To review the evidence for statin use in older adults.
  • To identify barriers to statin prescription and adherence in this demographic.
  • To propose strategies for optimizing statin therapy in appropriately selected older patients.

Main Methods:

  • Literature review focusing on clinical trials and observational studies.
  • Analysis of guidelines and recommendations for lipid management in the elderly.
  • Examination of factors influencing provider and patient adherence to statin therapy.

Main Results:

  • Evidence supports the benefit of lipid lowering in older adults, yet specific recommendations are limited.
  • Statin utilization is paradoxically lower in patients with higher cardiovascular risk, irrespective of age.
  • Suboptimal adherence to statin therapy is a significant challenge in older populations.

Conclusions:

  • Further research and updated guidelines are needed to clarify statin indications in older adults.
  • Strategies to improve statin prescription and adherence are essential for effective CVD prevention in the elderly.
  • Personalized approaches considering individual risk-benefit profiles are warranted for statin selection in older patients.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...